常用资源电子图书期刊论文学位会议外文资源特色专题内部出版物 
Elsevier电子期刊(6)
在“Elsevier电子期刊”中,命中:6条,耗时:0.1529273 秒

在所有数据库中总计命中:6

1.Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses
作者:Donald P. Tashkina ; dtashkin@mednet.ucla.edu" class="auth_mail" title="E-mail the corresponding author ; Eric D. Batemanb ; eric.bateman@uct.ac.za" class="auth_mail" title="E-mail the corresponding author ; Paul Jonesc ; pjones@sgul.ac.uk" class="auth_mail" title="E-mail the corresponding author ; Valentina B. Zubekd ; valentina.zubek@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Norbert Metzdorfe ; norbert.metzdorf@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Dacheng Liud ; dacheng.liu@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Thomas Leonardd ; thomas.leonard@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Emmanuelle Clerisme-Beatyd ; emmanuelle.clerisme-beaty@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Robert A. Wisef ; rwise@jhmi.edu" class="auth_mail" title="E-mail the corresponding author
刊名:Respiratory Medicine
出版年:2016
3.Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
作者:Prof Andreas du Bois ; MDa ; prof.dubois@googlemail.com" class="auth_mail" title="E-mail the corresponding author ; Prof Gunnar Kristensen ; PhDb ; Prof Isabelle Ray-Coquard ; MDc ; Alexander Reuss ; MScd ; Sandro Pignata ; MDe ; Prof Nicoletta Colombo ; MDf ; g ; Ursula Denison ; MDh ; Prof Ignace Vergote ; MDi ; Jose M del Campo ; MDj ; Petronella Ottevanger ; PhDk ; Martin Heubner ; MDl ; Thomas Minarik ; PhDm ; Emmanuel Sevin ; MDn ; Nikolaus de Gregorio ; MDo ; Prof Mariusz Bidziński ; MDp ; Prof Jacobus Pfisterer ; MDq ; Susanne Malander ; MDr ; Prof Felix Hilpert ; MDs ; Mansoor R Mirza ; MDt ; Prof Giovanni Scambia ; MDu ; Prof Werner Meier ; MDv ; Maria O Nicoletto ; MDw ; Prof Line Bjø ; rge ; PhDx ; Alain Lortholary ; MDy ; Martin Oliver Sailer ; PhDz ; Michael Merger ; MDz ; Philipp Harter ; MDa ; on behalf of the AGO Study Group led Gynecologic Cancer Intergroup (GCIG)/European Network of Gynaecologic Oncology Trials Groups (ENGOT) Intergroup Consortium
刊名:The Lancet Oncology
出版年:2016
4.Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes
作者:Hans-Ulrich Haeringa ; 1 ; hans-ulrich.haering@med.uni-tuebingen.de" class="auth_mail" title="E-mail the corresponding author ; Ludwig Merkerb ; 1 ; merker@dialyse-dormagen.de" class="auth_mail" title="E-mail the corresponding author ; Anita Vedel Christiansenc ; Flavien Rouxd ; flavien.roux.ext@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Afshin Salsalie ; afshin.salsali@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Gabriel Kimf ; woojae.kim@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Thomas Meinickeg ; thomas.meinicke@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Hans J. Woerlef ; hans-juergen.woerle@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; Uli C. Broedlf ; uli.broedl@boehringer-ingelheim.com" class="auth_mail" title="E-mail the corresponding author ; on behalf of the EMPA-REG EXTEND&trade ; METSU investigators
刊名:Diabetes Research and Clinical Practice
出版年:2015
6.Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
1
按检索点细分(6)
作者(4)
按出版年细分(6)
2016年(3)
2015年(3)

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700